Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11406565 Aseptic piercing system and method
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
December 6, 2018
Date of Patent
August 9, 2022
Patent Applicant
Regeneron Pharmaceuticals
Patent Application Number
16211280
Patent Citations
US Patent 10149947 Automatic drug injection device with sophisticated drive mechanism
US Patent 10912887 Automatic administration instrument for medical use
0
US Patent 10918788 Drive mechanism for drug delivery pumps with integrated status indication
US Patent 10918791 Devices, systems and methods for medicament delivery
0
US Patent 10926023 Sterilization arrangement for drug delivery device
0
US Patent 10933188 Fluid delivery device
US Patent 10933189 Variable rate controlled delivery drive mechanisms for drug delivery pumps
0
US Patent 10933192 Aseptic connections for drug delivery devices
0
US Patent 10946136 Delivery device with noise reducing component
0
US Patent 10953157 Sensor and sensor assembly for capacitive determination of a filling level
•••
Patent Inventor Names
Rachel Paige Arnott
0
Bart E. Burgess
0
Mike Stelmah
0
Michael Cupicha
0
Bryan Grygus
0
Alexei Goraltchouk
0
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11406565
Patent Primary Examiner
Philip R Wiest
CPC Code
A61J 1/201
A61J 1/2048
A61J 1/2072
A61J 1/1406
A61J 1/1443
A61M 5/2459
A61M 5/31511
A61M 39/18
A61M 2005/247
A61M 2005/2474
•••
Find more entities like US Patent 11406565 Aseptic piercing system and method
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE